Go Pro
NASDAQ:UTMD

Utah Medical Products (UTMD) Stock Price, News & Analysis

Utah Medical Products logo
$74.35 +0.30 (+0.41%)
Closing price 10/1/2026 04:00 PM Eastern
Extended Trading
$74.38 +0.03 (+0.03%)
As of 08:39 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Utah Medical Products Stock (NASDAQ:UTMD)

Advanced

Key Stats

Today's Range
$74.07
▼
$74.50
50-Day Range
$67.14
▼
$76.66
52-Week Range
$53.66
▼
$76.89
Volume
18,859 shs
Average Volume
34,511 shs
Market Capitalization
$236.43 million
P/E Ratio
22.67
Dividend Yield
1.67%
Price Target
N/A
Consensus Rating
Hold

Company Overview

Utah Medical Products, Inc. (NASDAQ:UTMD) develops, manufactures and distributes medical devices used primarily in women’s health, obstetrics, gynecology and neonatal care. The company focuses on single-use and specialty products designed for hospitals, clinics and other health-care settings.

Its product portfolio includes devices for fetal and maternal monitoring, labor and delivery, gynecologic procedures, neonatal care and electrosurgery. Utah Medical Products also offers related medical and surgical products used by physicians and clinical staff in diagnostic and therapeutic procedures.

Founded in 1978 and headquartered in Midvale, Utah, the company serves customers in the United States and international markets through direct sales and distribution channels. Its products are marketed to hospitals, physicians, medical facilities and other health-care providers.

AI Generated. May Contain Errors.

Utah Medical Products Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
14th Percentile Overall Score

UTMD MarketRank™: 

Utah Medical Products scored higher than 14% of companies evaluated by MarketBeat, and ranked 801st out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Utah Medical Products has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Utah Medical Products has only been the subject of 1 research reports in the past 90 days.

  • Read more about Utah Medical Products' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Utah Medical Products is 22.67, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.81.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Utah Medical Products is 22.67, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 272.66.

  • Price to Book Value per Share Ratio

    Utah Medical Products has a P/B Ratio of 2.00. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Utah Medical Products' valuation and earnings.
  • Percentage of Shares Shorted

    5.88% of the float of Utah Medical Products has been sold short.
  • Short Interest Ratio / Days to Cover

    Utah Medical Products has a short interest ratio ("days to cover") of 4.53.
  • Change versus previous month

    Short interest in Utah Medical Products has recently increased by 3.22%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Utah Medical Products pays a meaningful dividend of 1.67%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Utah Medical Products has only been increasing its dividend for 3 years.

  • Dividend Coverage

    The dividend payout ratio of Utah Medical Products is 37.80%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Utah Medical Products' dividend.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Utah Medical Products this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Utah Medical Products insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    8.00% of the stock of Utah Medical Products is held by insiders.

  • Percentage Held by Institutions

    69.60% of the stock of Utah Medical Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Utah Medical Products' insider trading history.
Receive UTMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Utah Medical Products and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

UTMD Stock News Headlines

Utah Medical Launches Tender Offer
MILLIONAIRE MASTERCLASS INVITE: Altucher
James Altucher says Elon Musk is preparing an unprecedented project set to surface on December 8th. Altucher is hosting a free masterclass revealing what he says is locked inside a sealed briefcase detailing Musk's plans. Attendees who join early can also access a $1,000 bonus offer included with the presentation.tc pixel
Utah Medical Products Inc's Dividend Analysis
See More Headlines

UTMD Stock Analysis - Frequently Asked Questions

Utah Medical Products' stock was trading at $55.96 at the beginning of the year. Since then, UTMD stock has increased by 32.9% and is now trading at $74.35.

Utah Medical Products, Inc. (NASDAQ:UTMD) released its quarterly earnings results on Thursday, July, 23rd. The medical instruments supplier reported $0.84 earnings per share (EPS) for the quarter. The medical instruments supplier earned $8.53 million during the quarter. Utah Medical Products had a net margin of 29.04% and a trailing twelve-month return on equity of 8.74%.

Shares of UTMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Utah Medical Products investors own include American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and AUO (AUOTY).

Company Calendar

Last Earnings
7/23/2026
Record date for 10/5 Dividend
9/17/2026
Ex-Dividend for 10/5 Dividend
9/17/2026
Today
10/02/2026
Dividend Payable
10/05/2026
Next Earnings (Estimated)
10/22/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Supplies
Current Symbol
NASDAQ:UTMD
CIK
706698
Employees
152
Year Founded
1978

Profitability

EPS (Trailing Twelve Months)
$3.28
Trailing P/E Ratio
22.67
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$11.29 million
Net Margins
29.04%
Pretax Margin
35.68%
Return on Equity
8.74%
Return on Assets
8.50%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
48.62
Quick Ratio
44.27

Sales & Book Value

Annual Sales
$38.52 million
Price / Sales
6.14
Cash Flow
$4.48 per share
Price / Cash Flow
16.60
Book Value
$37.23 per share
Price / Book
2.00

Miscellaneous

Outstanding Shares
3,180,000
Free Float
2,929,000
Market Cap
$236.43 million
Optionable
Not Optionable
Beta
0.38

Social Links

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (NASDAQ:UTMD) was last updated on 10/2/2026 by MarketBeat.com Staff.
From Our Partners